FDA recalls antidepressant duloxetine over cancer risk concerns

The FDA has recalled over 7,000 bottles of duloxetine (Cymbalta) after detecting a cancer-causing chemical, N-nitroso-duloxetine, in lot number 220128. This Class II recall highlights concerns over potential health risks. Patients are urged to consult their doctors before stopping medication, as the contaminant poses a low immediate risk but long-term exposure could elevate cancer risks.